Abstract
Background Lung function assessment is essential for respiratory medicine and health. Recommended international reference values differ by race, which is controversial. We evaluated the effect of adjusting lung function for race on prevalence of lung function impairment, breathlessness and mortality in the US population.
Methods Population-based analysis of the National Health and Nutrition Examination Survey (NHANES) 2007–2012. Race was analyzed as black, white, or other. Lung function was assessed as forced expired volume in one second (FEV1) and forced vital capacity (FVC). Predicted normal values were calculated for each person using the Global Lung Initiative (GLI)-2012 equations for 1) white; 2) black; and 3) other/mixed populations. Outcomes were compared for the different reference values in relation to: prevalence of lung function impairment (<lower limit of normal [LLN]), moderate/severe impairment (<50%pred); self-reported exertional breathlessness; and mortality up to 31 December, 2015.
Findings We studied 14,123 people (50% female); white (n=5,928), black (n=3,130), and other (n=5,065). Compared to those for white, black reference values identified markedly fewer cases of lung function impairment (FEV1) both in black people (9.3% vs. 36.9%) and other non-white races (1.5% vs. 9.5%); and prevalence of moderate/severe impairment was approximately halved. Outcomes among those impaired differed by reference value used: white (best outcomes), other/mixed (intermediate), and black (worst outcomes). Black people with FEV1 ≥LLNblack but <LLNwhite had 48% increased rate of breathlessness and almost doubled mortality, compared to blacks ≥LLNwhite. Lung function ≥LLNwhite identified people with good outcomes, similarly in black and white people. Findings were similar when analyzing FEV1 or FVC.
Interpretation Race adjustment of lung function should be abandoned. White reference values are most sensitive and specific to identify impairment, and could be applied across the population for improved assessment and health equity.
Funding Swedish Research Council (Dnr: 2019-02081).
Evidence before this study We searched MEDLINE and Embase using search terms including “race”, “ethnicity”, “pulmonary function”, “spirometry”, and “prediction equations” from database inception and January 10, 2022, for papers published in English. A total 33 papers related to lung function and race were identified. Race-adjusted lung function reference values were recommended by major guidelines for use internationally. Race-specific references assume a 10-15% lower lung function, such as the forced expired volume in one second (FEV1) and forced vital capacity (FVC), in black people and 4-6% lower in Asian people compared with in whites. Compared to not adjusting for race, race-adjusted lung function values have recently been questioned as they have been found to not improve prediction of outcomes in population-based studies or in people at risk of obstructive pulmonary disease. Concerns have been raised that, contrary to the intent, race-adjusted reference values may contribute to under diagnosis of disease in disadvantage minorities, with the largest differences reported in black (Afro-American) people, and may worsen race-related health inequalities. Data on the impact of race-adjusted lung function values across the ethnically diverse population are limited and data on how to decrease racial bias in lung function assessment are needed.
Added value of this study We analyzed the impact of using different race-specific (GLI-2012) reference equations for FEV1 and FVC across the US population in the National Health and Nutrition Examination Survey (NHANES) 2007-2012. Outcomes were prevalence of lung function impairment (value < lower limit of normal), breathlessness on exertion, and mortality up to December 31, 2015. Compared to using references for whites, black reference values were less likely to identify lung function impairment across all races but especially in blacks (9.3% vs. 36.9%); and those identified had lower lung function, more breathlessness, and worse prognosis. Black people with lung function normal by black standards but impaired by white standards had increased prevalence of breathlessness and mortality, compared to those normal also by white standards. Thus, race-adjusted reference values labeled black people as normal despite worse outcomes. White normal values identified people with similarly good lung function, and low rates of breathlessness and mortality across races groups.
Implications of all the available evidence The findings from this study support that race-adjusted reference values markedly under diagnose lung function impairment, and related breathlessness, and mortality in underprivileged groups across the US population. Normal values for whites were most sensitive to identify lung function impairment related to worsening outcomes and people classified as having normal lung function with similar good outcomes irrespective of race group. These findings suggest that lung function should not be adjusted for race. When applied across the population, white reference values were most sensitive to identify smaller or earlier impairment and most specific to identify people with normal lung function with similarly good outcomes across race groups. Given the large impact shown, abandoning the use of race-adjusted lung function values is likely to contribute to improved health equity.
Competing Interest Statement
ME discloses personal fees from Astra Zeneca outside this study. DM Is a former employee and current shareholder of GlaxoSmithKline and a consultant to AstraZeneca and the COPD Foundation, and is also an expert witness for the Schlesinger Law Firm.
Funding Statement
This study funded by an unrestricted grant from the Swedish Research Council (Dnr: 2019-02081).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This was a population-based analysis of the National Health and Nutrition Examination Survey (NHANES) in the US from 2007 to 2012. Participants provided written consent to participate in NHANES using a protocol approved by the National Center for Health Statistics Research Ethics Review Board. All the data are publicly available: https://www.cdc.gov/nchs/nhanes/index.htm
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used in the analyses are publicly available at: https://www.cdc.gov/nchs/nhanes/index.htm